November 17, 2016 - By Marie Mckinney · 0 Comments
Nov 17 is a negative day so far for iShares iBonds Dec 2025 Term Corporate (NYSEARCA:IBDQ) as the ETF is active during the day after losing 0.33% to hit $24.63 per share. The exchange traded fund has 51.74 million net assets and 0.58% volatility this month.
Over the course of the day 1,734 shares traded hands, as compared to an average volume of 22,280 over the last 30 days for iShares iBonds Dec 2025 Term Corporate (NYSEARCA:IBDQ).
The ETF is -4.86% of its 52-Week High and 5.77% of its low, and is currently having ATR of 0.18. This year’s performance is 4.63% while this quarter’s performance is -3.22%.
The ETF’s YTD performance is 8.26%, the 1 year is 7.97% and the 3 year is NaN%.
The fund’s top holdings are: Charter Comms Oper 144A 4.908% for 1.61% of assets, Bk Amer 3.875% for 1.46%, At&T 3.4% for 1.43%, Abbvie 3.6% for 1.36%, Medtronic 3.5% for 1.36%, Visa 3.15% for 1.31%, Jpmorgan Chase 3.9% for 1.28%, Actavis Fdg Scs 3.8% for 1.28%, Cvs Health 3.875% for 1.20%, Goldman Sachs Grp 4.25% for 1.10%.
More notable recent iShares iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ) news were published by: Forbes.com which released: “ETF Directory With Cost Ratings” on October 13, 2016, also Investmentnews.com with their article: “Bond ETFs’ resiliency surprises many investors” published on April 19, 2015, Nasdaq.com published: “iShares Outlines More Target Date Bond ETFs – ETF News And Commentary” on January 02, 2015. More interesting news about iShares iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ) were released by: Businesswire.com and their article: “Two iShares iBonds® ETFs Near Final Distribution Date” published on January 28, 2016 as well as Businesswire.com‘s news article titled: “BlackRock Announces Share Splits for iShares® iBonds® ETFs” with publication date: May 07, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marie Mckinney